To use all functions of this page, please activate cookies in your browser.
My watch list
my.bionity.com
my.bionity.com
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
2 Current news of Japan Tobacco
rss
Keryx Biopharmaceuticals Announces Positive Top-Line Results from Phase 3 Study of Ferric Citrate
25-04-2012
Keryx Biopharmaceuticals, Inc. announced that its Japanese partner, Japan Tobacco Inc. (JT) and Torii Pharmaceutical Co., Ltd. (Torii), has announced positive top-line results from a Phase 3 study of ferric citrate in Japan for the treatment of hyperphosphatemia in end-stage renal disease ...
Gilead Announces the Advancement of HIV Integrase Inhibitor GS 9137 to a Phase II Clinical Trial
11-01-2006
Gilead Sciences, Inc. announced that it has completed a Phase I/II study of JTK-303, or GS 9137, an oral HIV integrase inhibitor for the treatment of HIV licensed from Japan Tobacco (JT) in March 2005. The company anticipates presenting results from the Phase I/II dose-escalation study, which ...
Page 1 From 1
Netmeeting
